IS2472B - Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau - Google Patents

Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau

Info

Publication number: IS2472B
Authority: IS; Iceland
Prior art keywords: pharmaceutical compositions; compositions containing; production method; represent; independently
Prior art date: 2000-01-06

Application number

IS6452A

Other languages

English (en)

Other versions

IS6452A (is

Inventor

Baroni Marco

Bourrie Bernard

Cardamone Rosanna

Casellas Pierre

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-06

Filing date

2002-06-28

Publication date

2008-12-15

2002-06-28 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2002-06-28 Publication of IS6452A publication Critical patent/IS6452A/is

2008-12-15 Publication of IS2472B publication Critical patent/IS2472B/is

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical compound C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
239000011593 sulfur Substances 0.000 abstract 1
125000004434 sulfur atom Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)

IS6452A 2000-01-06 2002-06-28 Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau IS2472B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0000113A FR2803593B1 (fr)	2000-01-06	2000-01-06	Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR2000/003741 WO2001049684A1 (fr)	2000-01-06	2000-12-29	Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number	Publication Date
IS6452A IS6452A (is)	2002-06-28
IS2472B true IS2472B (is)	2008-12-15

Family

ID=8845654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6452A IS2472B (is)	2000-01-06	2002-06-28	Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau

Country Status (27)

Country	Link
US (1)	US6689797B2 (is)
EP (1)	EP1248785B1 (is)
JP (1)	JP2004501861A (is)
KR (1)	KR100755103B1 (is)
CN (1)	CN1200939C (is)
AT (1)	ATE297918T1 (is)
AU (1)	AU782650B2 (is)
BR (1)	BR0016921A (is)
CA (1)	CA2395969C (is)
CZ (1)	CZ300658B6 (is)
DE (1)	DE60020885T2 (is)
EA (1)	EA004858B1 (is)
EE (1)	EE04814B1 (is)
FR (1)	FR2803593B1 (is)
HU (1)	HU224815B1 (is)
IL (1)	IL150605A0 (is)
IS (1)	IS2472B (is)
ME (1)	MEP21808A (is)
MX (1)	MXPA02006709A (is)
NO (1)	NO322598B1 (is)
NZ (1)	NZ519723A (is)
PL (1)	PL202761B1 (is)
RS (1)	RS50432B (is)
SK (1)	SK285557B6 (is)
UA (1)	UA72017C2 (is)
WO (1)	WO2001049684A1 (is)
ZA (1)	ZA200205223B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL149250A0 (en) *	1999-10-22	2002-11-10	Sanofi Synthelabo	Phenyl-and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
FR2831166B1 (fr) *	2001-10-18	2004-02-27	Sanofi Synthelabo	Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
FR2832405B1 (fr) *	2001-11-19	2004-12-10	Sanofi Synthelabo	Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant
UA77526C2 (en) *	2002-06-07	2006-12-15	Sanofi Aventis	Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
FR2862968B1 (fr) *	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de 4-[(arylmethyl)aminomethyl]piperidine, leur preparation et leur application en therapeutique
FR2862967B1 (fr) *	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique
EP2137162B1 (en) *	2007-03-15	2018-08-01	Novartis AG	Organic compounds and their uses
US20100041663A1 (en)	2008-07-18	2010-02-18	Novartis Ag	Organic Compounds as Smo Inhibitors
FR2953836B1 (fr) *	2009-12-14	2012-03-16	Sanofi Aventis	Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
US11129746B2 (en)	2010-06-23	2021-09-28	Dental Choice Holdings Llc	Method and oral appliance for improving air intake and reducing bruxism
EP2606894A1 (en)	2011-12-20	2013-06-26	Sanofi	Novel therapeutic use of p75 receptor antagonists
US11795148B2 (en)	2017-12-12	2023-10-24	Queen's University At Kingston	Compounds and methods for inhibiting CYP26 enzymes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2060816C3 (de)	1970-12-10	1980-09-04	Merck Patent Gmbh, 6100 Darmstadt	4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
US5273977A (en) *	1990-11-05	1993-12-28	Warner-Lambert Company	Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
PT100441A (pt) *	1991-05-02	1993-09-30	Smithkline Beecham Corp	Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
FR2736053B1 (fr) *	1995-06-28	1997-09-19	Sanofi Sa	Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
GB9604036D0 (en) *	1996-02-26	1996-04-24	Merck Sharp & Dohme	Therapeutic agents
FR2751645B1 (fr) *	1996-07-29	1998-12-24	Sanofi Sa	Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
DE19826841A1 (de) *	1998-06-16	1999-12-23	Merck Patent Gmbh	Arylalkanoylpyridazine

2000
- 2000-01-06 FR FR0000113A patent/FR2803593B1/fr not_active Expired - Fee Related
- 2000-12-29 EA EA200200611A patent/EA004858B1/ru not_active IP Right Cessation
- 2000-12-29 JP JP2001550224A patent/JP2004501861A/ja active Pending
- 2000-12-29 DE DE60020885T patent/DE60020885T2/de not_active Expired - Lifetime
- 2000-12-29 BR BR0016921-8A patent/BR0016921A/pt not_active IP Right Cessation
- 2000-12-29 RS YUP-513/02A patent/RS50432B/sr unknown
- 2000-12-29 CA CA002395969A patent/CA2395969C/en not_active Expired - Fee Related
- 2000-12-29 EE EEP200200382A patent/EE04814B1/xx not_active IP Right Cessation
- 2000-12-29 ME MEP-218/08A patent/MEP21808A/xx unknown
- 2000-12-29 AT AT00990851T patent/ATE297918T1/de not_active IP Right Cessation
- 2000-12-29 CN CNB008187592A patent/CN1200939C/zh not_active Expired - Fee Related
- 2000-12-29 EP EP00990851A patent/EP1248785B1/fr not_active Expired - Lifetime
- 2000-12-29 AU AU30311/01A patent/AU782650B2/en not_active Ceased
- 2000-12-29 WO PCT/FR2000/003741 patent/WO2001049684A1/fr not_active Ceased
- 2000-12-29 CZ CZ20022302A patent/CZ300658B6/cs not_active IP Right Cessation
- 2000-12-29 KR KR1020027008638A patent/KR100755103B1/ko not_active Expired - Fee Related
- 2000-12-29 PL PL357082A patent/PL202761B1/pl not_active IP Right Cessation
- 2000-12-29 US US10/169,528 patent/US6689797B2/en not_active Expired - Fee Related
- 2000-12-29 NZ NZ519723A patent/NZ519723A/en not_active IP Right Cessation
- 2000-12-29 HU HU0204394A patent/HU224815B1/hu not_active IP Right Cessation
- 2000-12-29 UA UA2002065297A patent/UA72017C2/uk unknown
- 2000-12-29 SK SK962-2002A patent/SK285557B6/sk not_active IP Right Cessation
- 2000-12-29 IL IL15060500A patent/IL150605A0/xx not_active IP Right Cessation
- 2000-12-29 MX MXPA02006709A patent/MXPA02006709A/es active IP Right Grant
2002
- 2002-06-28 ZA ZA200205223A patent/ZA200205223B/en unknown
- 2002-06-28 IS IS6452A patent/IS2472B/is unknown
- 2002-07-04 NO NO20023251A patent/NO322598B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2395969C (en)	2009-05-19
UA72017C2 (en)	2005-01-17
US6689797B2 (en)	2004-02-10
ATE297918T1 (de)	2005-07-15
ZA200205223B (en)	2004-01-26
EA004858B1 (ru)	2004-08-26
KR100755103B1 (ko)	2007-09-04
MXPA02006709A (es)	2002-10-23
WO2001049684A1 (fr)	2001-07-12
AU3031101A (en)	2001-07-16
NO20023251L (no)	2002-09-06
CZ300658B6 (cs)	2009-07-08
SK9622002A3 (en)	2003-03-04
KR20020063291A (ko)	2002-08-01
DE60020885D1 (de)	2005-07-21
PL202761B1 (pl)	2009-07-31
YU51302A (sh)	2005-06-10
PL357082A1 (en)	2004-07-12
CN1433412A (zh)	2003-07-30
AU782650B2 (en)	2005-08-18
BR0016921A (pt)	2002-10-15
NO322598B1 (no)	2006-10-30
EP1248785A1 (fr)	2002-10-16
EA200200611A1 (ru)	2002-12-26
NZ519723A (en)	2005-08-26
HU224815B1 (en)	2006-02-28
FR2803593A1 (fr)	2001-07-13
RS50432B (sr)	2009-12-31
EE200200382A (et)	2003-12-15
SK285557B6 (sk)	2007-03-01
EP1248785B1 (fr)	2005-06-15
US20030083347A1 (en)	2003-05-01
MEP21808A (en)	2010-06-10
HUP0204394A3 (en)	2005-04-28
EE04814B1 (et)	2007-04-16
CN1200939C (zh)	2005-05-11
IS6452A (is)	2002-06-28
HK1050532A1 (en)	2003-06-27
DE60020885T2 (de)	2006-05-11
IL150605A0 (en)	2003-02-12
FR2803593B1 (fr)	2002-02-15
CZ20022302A3 (cs)	2002-10-16
JP2004501861A (ja)	2004-01-22
HUP0204394A2 (en)	2003-05-28
CA2395969A1 (en)	2002-07-03
NO20023251D0 (no)	2002-07-04

Publication	Publication Date	Title
AR034268A1 (es)	2004-02-18	Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion
CY1110240T1 (el)	2015-01-14	Νεα παραγωγα 2η-πυριδαζινο-3-ονης, φαρμακευτικες συνθεσεις που τα περιεχουν και μεθοδος για την παρασκευη του δραστικου συστατικου
IL160304A (en)	2010-12-30	Compounds and composition for activating peroxisome proliferators-responsive receptor ??
HUP0002112A2 (hu)	2000-09-28	Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
IL150650A0 (en)	2003-02-12	Piperidine derivatives and pharmaceutical compositions containing the same
NZ536734A (en)	2006-03-31	Spiroindolinepiperidine derivatives
PL365007A1 (en)	2004-12-27	Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
IS6452A (is)	2002-06-28	Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau
DE60239170D1 (de)	2011-03-24	Bicyclische Verbindungen
CO4980887A1 (es)	2000-11-27	Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico
NO972887L (no)	1997-08-20	Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
YU43902A (sh)	2005-03-15	Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
MXPA04003568A (es)	2004-07-30	Aralquil-tetrahidro-piridinas su preparacion y composiciones farmaceuticas que contienen las mismas.
EA200300458A1 (ru)	2003-08-28	Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их
YU13003A (sh)	2006-05-25	Prolekovi za ligande nmda receptora
ATE365162T1 (de)	2007-07-15	Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
ATE502034T1 (de)	2011-04-15	Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
MEP12408A (en)	2010-06-10	Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors
NZ504299A (en)	2001-01-26	1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0303349A2 (hu)	2004-01-28	Szubsztituált bifenilszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerészeti készítmények
EA200001157A2 (ru)	2001-06-25	Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции
GEP20074217B (en)	2007-10-10	Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
ATE500241T1 (de)	2011-03-15	Phenyl- und pyridyl-piperidine mit tnf-wirkung
DK104488D0 (da)	1988-02-26	Acetamider afledt af 2,3-dihydro-3-phenyl-2-benzofuranon, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem